Skip to main content
. 2017 Feb 10;10(2):229–240. doi: 10.1016/j.tranon.2016.12.011

Figure 3.

Figure 3

Effect of VPA, MSNs, and VPA-MSNs on C6 and U87 glioma cell viability. C6 and U87 gliomas were treated with various concentrations of VPA, MSNs, and VPA-MSNs for 12 or 24 hours, and cell viability were examined with MTT assay. Cell viability was calculated relative to untreated controls.